ELXR.H — Elixxer Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -24756.72% |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 0.17 | 1.65 | 1.1 | 0.04 | 0.08 | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Elixxer Ltd. is a Canada-based investment company. The Company has investments and activities in the legal cannabis sector. The Company is focused on investing opportunities in various sectors, with a priority on growth companies that are past the start-up phase.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- July 9th, 2004
- Public Since
- November 24th, 2005
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
TSX Venture Exchange
- Shares in Issue
- 11,338,887

- Address
- 800 Place Victoria Suite 3700, MONTREAL, H4Z 1E9
- Web
- https://www.elixxer.com/
- Phone
- +1 5143977400
- Auditors
- Kreston GTA LLP
Upcoming Events for ELXR.H
Q2 2024 Elixxer Ltd Earnings Release
Q3 2024 Elixxer Ltd Earnings Release
Similar to ELXR.H
49 North Resources
TSX Venture Exchange
AI Artificial Intelligence Ventures
TSX Venture Exchange
Alset AI Ventures
TSX Venture Exchange
Banxa Holdings
TSX Venture Exchange
BIGG Digital Assets
TSX Venture Exchange
FAQ
As of Today at 20:25 UTC, shares in Elixxer are trading at CA$1.15. This share price information is delayed by 15 minutes.
Shares in Elixxer last closed at CA$1.15 and the price had moved by -23.33% over the past 365 days. In terms of relative price strength the Elixxer share price has underperformed the Toronto Stock Exchange 300 Composite Index by -39.02% over the past year.
There is no consensus recommendation for this security.
Find out moreElixxer does not currently pay a dividend.
Elixxer does not currently pay a dividend.
Elixxer does not currently pay a dividend.
To buy shares in Elixxer you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$1.15, shares in Elixxer had a market capitalisation of .
Here are the trading details for Elixxer:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: ELXR
Based on an overall assessment of its quality, value and momentum Elixxer is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elixxer. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -18.27%.
As of the last closing price of CA$1.15, shares in Elixxer were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Elixxer PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$1.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Elixxer's management team is headed by:
- Ferras Zalt - CHM
- Kym No - CFO
- Tarik Alhaidary - DRC
- Jeff Cheah - IND
- Rafi Hazan - IND